Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The In-Vitro Toxicology Testing Market Expected To Expand Between 2025 And 2029?
The in-vitro toxicology testing market size has experienced substantial growth in recent years. It is anticipated to expand from $11.53 billion in 2024 to $12.73 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.4%. This historical growth can be linked to factors such as regulatory mandates, ethical considerations and animal welfare, enhanced cost and time efficiency, the worldwide expansion of the pharmaceutical industry, the demands of drug discovery and development, and heightened public awareness concerning environmental toxins.
The in-vitro toxicology testing market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $19.02 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. Factors contributing to this growth during the forecast period include an increased emphasis on personalized medicine, a rising demand for predictive toxicology models, the broadening scope of environmental testing, challenges in oncology drug development, a focus on screening endocrine disruptors, and a movement towards multi-organ chip technologies. Key trends expected throughout this period encompass progress in 3D cell culture technologies, the integration of high-throughput screening, a heightened focus on organ-on-a-chip technologies, their application in chemical safety assessments, the utilization of human-derived cell lines, the incorporation of omics technologies, and various educational initiatives and training programs.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7987&type=smp
Which Industry Drivers Are Expected To Accelerate The In-Vitro Toxicology Testing Market From 2025 To 2029?
The in-vitro toxicology testing market is expected to be propelled by increasing healthcare expenditure. Health expenditure signifies the financial resources dedicated by both citizens and the government from their total earnings towards hospitals, home health services, prescription pharmaceuticals, nursing facilities, and personal healthcare. Globally, health expenditure is seeing an increase due to the rising prevalence of diseases that necessitate in-vitro toxicology testing. For instance, in September 2024, a report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, indicated that from 2023 to 2032, the average growth rate of national health expenditure (NHE) is projected to be 5.6%, which exceeds the average GDP growth rate of 4.3%. Consequently, the proportion of health spending as a percentage of GDP is anticipated to climb from 17.3% in 2022 to 19.7% in 2032. Therefore, the expanding healthcare expenditure is serving as a driving force for the in-vitro toxicology testing market.
What Are The Major Segments Identified In The In-Vitro Toxicology Testing Market?
The in-vitro toxicology testingmarket covered in this report is segmented –
1) By Product And Service: Consumables; Assays; Equipment; Software; Services
2) By Method: Cellular Assays; Biochemical Assays; In Silico Models; Ex Vivo Models
3) By Technology: Cell Culture Technologies; High-throughput Technologies; Toxicogenomics
4) By Applications: Neurotoxicity; Dermal toxicity; Cytotoxicity; Other Applications
5) By Industry: Pharmaceuticals And Biopharmaceuticals; Cosmetic And Household Products; Food; Chemicals
Subsegments:
1) By Consumables: Reagents; Cell Culture Media; Plates And Vials
2) By Assays: Cell-Based Assays; Biochemical Assays; Genetic Toxicity Assays
3) By Equipment: Automated Systems; Microscopes; Plate Readers
4) By Software: Data Analysis Software; Laboratory Information Management Systems (LIMS); Toxicology Modeling Software
5) By Services: Testing Services; Consultation Services; Regulatory Compliance Services
What Key Innovation Trends Are Fueling Advancements In The In-Vitro Toxicology Testing Market?
Innovative cell therapy development is emerging as a significant trend within the in-vitro toxicology market. Leading firms in the in-vitro toxicology testing market are concentrating on creating novel funding approaches to solidify their standing. As an illustration, Waypoint Bio, a US-based Biotechnology company, disclosed securing $14.5 million in seed funding in June 2024 for advanced cell therapies targeting solid tumors, utilizing in vivo spatial pooled screening technology. This platform uniquely combines spatial biology with pooled screening, enabling concurrent analysis of the interactions between diverse cell therapy candidates and the solid tumor microenvironment. The system quantifies numerous phenotypes at the single-cell resolution, empowering researchers to discern not only the efficacy of therapies but also the reasons for their success or failure through their interactions within the tumor environment.
Who Are The Key Multinational Companies Dominating The In-Vitro Toxicology Testing Market?
Major companies operating in the in-vitro toxicology testing market are Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (LabCorp), Gentronix Limited (a subsidiary of Eurofins Scientific SE), Bio-Rad Laboratories Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Promega Corporation, Agilent Technologies Inc., Evotec SE, SGS SA, BioIVT LLC, MB Research Laboratories LLC, Creative Biolabs Inc., Creative Bioarray Inc., InSphero AG, PerkinElmer Inc., Cyprotex PLC, MatTek Corporation, Danaher Corporation, Ncardia AG, Sekisui Chemical Co. Ltd., BioReliance Corporation, CellSystems Biotechnologie Vertrieb GmbH, Taconic Biosciences Inc., Biopredic International, MultiCell Technologies Inc., Altasciences Clinical Research Holdings Inc., Molecular Toxicology Inc., Toxys BV, XenoTech LLC, Optivia Biotechnology Inc., Toxikon Corporation
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
Which Region Is Projected To Lead The In-Vitro Toxicology Testing Market During The Forecast Period?
North America was the largest region in the in- vitro toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the in- vitro toxicology testing market report during the forecast period. The regions covered in the in-vitro toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The In-Vitro Toxicology Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=7987&type=smp
Browse Through More Reports Similar to the Global In-Vitro Toxicology Testing Market 2025, By The Business Research Company
Veterinary Laboratory Testing Services Global Market Report 2025
In Vitro Diagnostics Ivd Quality Control Global Market Report 2025
Veterinary Reference Laboratory Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model